Related Experiment Video

Updated: Aug 1, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in

Q Li1, M Tsujita, S Yokoyama

  • 1Biochemistry I, Nagoya City University Medical School, Japan.

Biochemistry
|October 7, 1997
PubMed

Insights

Apolipoprotein A-I facilitates cellular cholesterol efflux by mobilizing intracellular cholesterol, forming prebeta high-density lipoprotein (HDL) particles. Protein kinase C inhibition disrupts this process, impacting HDL composition and cholesterol transport.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Lipid Metabolism

Background:

  • High-density lipoprotein (HDL) metabolism is crucial for reverse cholesterol transport.
  • Apolipoprotein A-I (apoA-I) is the primary protein component of HDL and plays a key role in cholesterol removal from cells.

Purpose of the Study:

  • To investigate the mechanism of apolipoprotein-mediated cellular cholesterol efflux.
  • To elucidate the role of intracellular signaling pathways, specifically protein kinase C (PKC), in apoA-I-induced cholesterol removal.
  • To characterize the composition of high-density lipoprotein (HDL) particles generated during this process.

Main Methods:

  • Cholesterol-loaded mouse peritoneal macrophages were treated with apolipoprotein A-I.
  • The effect of phorbol myristate and protein kinase C (PKC) inhibitors (H7, staurosporine) on cholesterol and phospholipid efflux was assessed.
  • The availability of cellular cholesterol for acyl-CoA:cholesterol acyltransferase (ACAT) was measured.
  • The composition of generated prebeta high-density lipoprotein (HDL) particles was analyzed.

Main Results:

  • Apolipoprotein A-I mediated the removal of both cholesterol and phospholipid, forming prebeta HDL particles with a 1:1 cholesterol to phosphatidylcholine ratio.
  • PKC inhibition significantly reduced apoA-I-mediated cholesterol efflux, leading to cholesterol-poor prebeta HDL (1:10 ratio), without affecting apoA-I binding or phospholipid efflux.
  • ApoA-I treatment depleted ACAT-available cellular cholesterol, an effect reversed by PKC inhibitors, while nonspecific efflux did not impact this pool.

Conclusions:

  • Apolipoprotein-mediated cholesterol efflux involves the mobilization of intracellular cholesterol from the ACAT pool to a specific pool for prebeta HDL generation.
  • This process is dependent on apolipoprotein-cell interaction and subsequent intracellular signaling, requiring PKC activity.
  • Cell surface binding of apolipoprotein is essential for prebeta HDL assembly, and intracellular cholesterol mobilization enriches the HDL particle.

More Related Videos

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans11:07

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...